Vistra Corp. (BIT:1VST)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	61,145	45,307	12,460	8,639	9,663	7,861
Market Cap Growth	63.99%	263.61%	44.24%	-10.60%	22.92%	-21.27%
Enterprise Value	78,133	65,211	24,044	22,097	19,799	16,174
PE Ratio	29.58	19.01	10.26	-	-	15.12
PS Ratio	3.65	2.72	0.93	0.67	0.91	0.84
PB Ratio	13.66	8.40	2.59	1.88	1.33	1.15
P/FCF Ratio	26.77	18.88	3.65	-	-	4.63
P/OCF Ratio	13.63	10.28	2.53	19.04	-	2.88
EV/Sales Ratio	4.98	3.92	1.80	1.72	1.86	1.73
EV/EBITDA Ratio	13.14	9.98	5.73	25.98	40.07	5.09
EV/EBIT Ratio	23.43	16.54	9.81	-	-	10.58
EV/FCF Ratio	34.20	27.17	7.04	-	-	9.52
Debt / Equity Ratio	3.66	3.12	2.77	2.73	1.36	1.23
Debt / EBITDA Ratio	2.58	2.54	3.11	13.60	17.83	2.60
Debt / FCF Ratio	7.18	7.01	3.90	-	-	4.96
Quick Ratio	0.26	0.38	0.53	0.26	0.56	0.56
Current Ratio	0.86	0.96	1.19	1.08	1.35	1.13
Asset Turnover	0.47	0.49	0.45	0.44	0.44	0.44
Return on Equity (ROE)	41.68%	51.57%	29.14%	-18.32%	-15.18%	7.65%
Return on Assets (ROA)	6.30%	7.21%	5.15%	-2.21%	-3.31%	4.51%
Return on Capital (ROIC)	10.40%	11.85%	8.82%	-3.64%	-4.75%	6.13%
Return on Capital Employed (ROCE)	13.50%	13.90%	11.70%	-	-	8.40%
Earnings Yield	3.38%	5.67%	10.84%	-13.29%	-11.59%	6.61%
Earnings Yield	3.38%	5.67%	10.84%	-13.29%	-11.59%	6.61%
FCF Yield	3.74%	5.30%	27.42%	-8.84%	-11.27%	21.61%
Payout Ratio	20.82%	17.98%	31.01%	-	-	41.82%
Buyback Yield / Dilution	4.18%	6.03%	11.19%	12.39%	1.81%	1.77%

Source: S&P Global Market Intelligence. Utility template. Financial Sources.